rs397517003
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001005242.3(PKP2):c.1556+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.00000124 in 1,612,060 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001005242.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 250998Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135650
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459900Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726322
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74326
ClinVar
Submissions by phenotype
Arrhythmogenic right ventricular dysplasia 9 Pathogenic:2
This sequence change affects a donor splice site in intron 7 of the PKP2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PKP2 are known to be pathogenic (PMID: 15489853, 17041889, 23911551). This variant is present in population databases (rs397517003, gnomAD 0.0009%). Disruption of this splice site has been observed in individual(s) with arrhythmogenic right ventricular cardiomyopathy and/or arrythmogenic cardiomyopathy (PMID: 20400443, 31386562). This variant is also known as IVS7+1G>A. ClinVar contains an entry for this variant (Variation ID: 45038). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
- -
Arrhythmogenic right ventricular cardiomyopathy Pathogenic:1
The c.1688+1G>A variant in PKP2 has been identified in 2 individuals with ARVC (Fressart 2010, LMM data) and 1/113356 European chromosomes by gnomAD (https://gnomad.broadinstitute.org). This variant occurs within the canonical splice site (+/- 1,2) and is predicted to cause altered splicing leading to an abnormal or absent protein. Loss of function of the PKP2 gene is an established disease mechanism in autosomal dominant arrhythmogenic right ventricular cardiomyopathy (ARVC). This variant has also been reported in ClinVar (Variation ID 45038). In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant ARVC. ACMG/AMP Criteria applied: PVS1, PM2, PS4_Supporting. -
Cardiomyopathy Pathogenic:1
This variant causes a G>A nucleotide substitution at the +1 position of intron 7 of the PKP2 gene. Splice site prediction tools predict that this variant may have a significant impact on RNA splicing. Although functional studies have not been performed for this variant, this variant is expected to result in an absent or non-functional protein product. This variant has been reported in two individuals affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 20400443; Clinvar variation ID 45038). This variant has been identified in 1/250998 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of PKP2 function is a known mechanism of disease. Based on the available evidence, this variant is classified as Likely Pathogenic. -
not provided Pathogenic:1
Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30790397, 34697415, 20400443, 28523642, 31402444, 34469894, AlSafF2023[Preprint], 35463915, 31386562) -
Cardiovascular phenotype Pathogenic:1
The c.1688+1G>A intronic pathogenic mutation results from a G to A substitution one nucleotide after coding exon 7 of the PKP2 gene. This alteration has been reported in association with arrhythmogenic right ventricular cardiomyopathy (ARVC) (Fressart V et al. Europace, 2010 Jun;12:861-8; Hermida A et al. Eur J Heart Fail, 2019 06;21:792-800; van Lint FHM et al. Circ Genom Precis Med, 2019 08;12:e002467). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In silico splice site analysis predicts that this alteration will weaken the native splice donor site. In addition to the clinical data presented in the literature, alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at